Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That’s not what I heard AT ALL: as I recall, the video claims that the (ENTIRE) STEM CELL INDUSTRY (space)—of which CELZ is a PART—will be worth an estimated $6B by 2021. Is that not what it says?
Wow—that’s some perspective!
That posture is starting to seem a bit delusional to me...
And didn’t 777 share that 2/4 needed signatures for Holland have been secured —meaning that its funding stream is NOT established? Beyond that, I’m trying desperately to understand how management went so long with <100M OS only now to balloon to the current levels: WHAT WERE THEY THINKING?! Should they not have diluted gradually from
MUCH earlier on?
I emailed several local
urologists last summer to gauge awareness/interest: CRICKETS. NOT at all encouraging...
Good email indeed. The longer they wait to release the results, the greater the skepticism about them. According to the very social media approach that you cite, we have known about ALLEGED CaverStem efficacy approaching 90% for OVER a year now. Seriously?Are we measuring time with sundials again, reckoning figures with the abacus? UNREAL
Where? I’d like to see.
NOT at all likely that this goes from subs to $15-25 PPS in a less than 2 years (show me another stock that has moved this way—with links to verify the analysis). NOW, if they had sustained the movement almost a year ago that led to .07, I could believe it much more easily. “Anemic” comes to mind.
Which ad? Link and/or picture, please. Otherwise it’s hearsay
I like that display, monte—which platform?
So what, then, are investment firms like IBEX drawn to? Are you saying they are ignorant and clueless with their money, which they essentially toss into the wind?
OH YES I DO
When REVs surpass expenses (as is expected in 2019), the volume will BLAST the resistance—no matter how concerted—out of the way.
As long as IBEX remains committed, I’m committed.
Not knowing a lot about the science behind BLSP’s business model, I was naturally curious and inquisitive. It is my understanding that animal waste is one potentially plentiful source of material for your AD process. Is it possible/practical to consider building AD sites at municipal solid waste facilities and use human excrement in same way that presumably animal dung is used?
This will greatly reduce volume of waste handled by existing sanitation systems and provide AMPLE volume for power generation through AD—if I am looking at this in any way correctly.
Many existing municipal sanitation facilities are also often approximate to power grids (these sorts of things tending to be clustered in/away from certain sections of towns/cities). These factors could motivate many municipal governments to invest in the infrastructure needed to incorporate such AD processes—probably in exchange for the rights to some of the power generated.
Thoughts? Refinements? Corrections?
Serious question: who CAN short on OTCs? Someone obviously is, but brokerages won’t lend the money, that’s for sure. Are these cash-flush self-funded shorters?
Thanks for that informative perspective, JB!
Correct. Their value may be comparatively low NOW, but in time their assets will dominate this space. Buy and forget imho
Three years ago: old news. However, it does make one ask why we haven’t heard more about the commercialization of AngioStem in those 3 years...
Generally speaking, grants are awarded with the reasonable expectation and mutual understanding that the awardee CAN AND WILL perform certain actions to a certain standard—and little else beyond that typically.
It would be pleasantly refreshing to get an actual response from a firm in which I’m invested. So rare (sadly)...
Where on social media is the discussion specifically about a share BB?
While I don’t know enough about the tenets of your argument, I DO know enough about critical thinking and interpretation to declare my conviction that you yourself believe in the merits of the nuanced distinctions you’re making—which IS encouraging.
Thanks for your informed and intelligent response. Many are just trying to understand the basis for and prospects of recovery from the “bottom of the barrel” anytime soon (6 months or less). When is the 8-K due?
Sad to contemplate the chance that you are right—but even sadder to see that NOTHING they are doing is counteracting these impressions (for about a year now)...
I’m fine with your overall approach, monte. What I do NOT like is the unwillingness even to engage in a discussion on more qualitative matters with those who have the patience, willingness, and often the wherewithal to HELP: as I have noted at a few points along the way, some of the PRs—in addition to coming less frequently than previously—have fairly simple (and embarrassing) errors of both style (more subjective) and, worse still, of substance (more objective).
I have emailed DD several times: crickets
Yeah—public companies don’t need shareholders (eye roll)
Yes. I am CONTRASTING pump and dump vs. what CELZ has done over the last year (which is the opposite): there is SO much that they could say to validate and substantiate critical elements of their business plan and organic growth—but they do NOTHING of the sort. I’ve had shares for a little over a year.
While I agree with the spirit of much that you say here, surely there is a middle ground between baseless pump and dump and comparative silence regarding almost anything of substance that would validate their business plan, their financial outlook, and other matters of concern for anyone investing in any “legitimate” company. I was ahead of most (and took my share of abuse) for calling them out on vagaries and lack of reasonable detail THEN (almost 1 year ago): if anything, they have gotten worse, not better—and long-term shareholders who continue to bankroll their endeavors to a substantial degree deserve to know WITH they are up to with considerable more specificity.
Truth. Let’s assume for the sake of argument that one wanted a competitive/viable alternative with comparable results—what would it be? (CRICKETS)
We don’t need conversations with the CEO or shamanistic visions: we need results—and fairly frequent updates (monthly is a good practice) indicating increments of progress toward clearly enumerated revenue growth and profit goals. No more 40,000 ft views.
No, I totally expect it will happen (and in 2019)—but I don’t think we’ll get official word of it until the annual report in April 2020 (just as now, I expect they won’t release a 4th quarter in Feb, waiting instead to report Q4 with the annual numbers in April). This is consistent with their apparent preference: the MORE they have going in, the LESS they talk about it in shareholder updates.
+1
It may OCCUR in 2019, but based on their established patterns, I anticipate WORS of it in April 2020.
Enquiring minds have been asking this question for 6 months or more
No volume as yet today?